| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |